Vaishali Pharma reports Profit after tax of Rs -14.49 Mln, in the March 2021 quarter

The sales declined to Rs. 188.82 millions for the March 2021 quarter as compared to Rs. 211.45 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2021 is Rs. -14.49 millions as compared to Net Loss of Rs. -8.16 millions of corresponding quarter ended March 2020 Operating profit Margin for the quarter ended March 2021 further decreased to -7.87% as compared to -0.16% of corresponding quarter ended March 2020

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202103	202003	% Var	202103	202003	% Var	202003	201903	% Var
Sales	188.82	211.45	-10.70	537.74	600.86	-10.50	600.86	750.91	-19.98
Other Income	5.73	13.68	-58.11	18.09	22.27	-18.77	21.73	19.82	9.64
PBIDT	-7.87	-0.16	4818.75	44.41	30.52	45.51	29.98	40.40	-25.79
Interest	10.67	7.23	47.58	26.10	24.81	5.20	24.81	26.39	-5.99
PBDT	-18.54	-7.39	150.88	18.31	5.71	220.67	5.17	14.01	-63.10
Depreciation	1.13	3.29	-65.65	4.27	5.12	-16.60	4.38	2.69	62.83
PBT	-19.67	-10.68	84.18	14.04	0.59	2279.66	0.79	11.32	-93.02
TAX	-5.18	-2.52	105.56	3.59	0.46	680.43	0.46	4.19	-89.02
Deferred Tax	-0.20	-0.10	100.00	-0.20	-0.10	100.00	-0.10	-0.31	-67.74
PAT	-14.49	-8.16	77.57	10.45	0.13	7938.46	0.33	7.13	-95.37
Equity	105.46	105.46	0.00	105.46	105.46	0.00	105.46	105.46	0.00
PBIDTM(%)	-4.17	-0.08	5405.94	8.26	5.08	62.59	4.99	5.38	-7.26